NASDAQ · SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC · LARGE CAP
Surgery Partners, Inc. SGRY
12 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$3.3B
▲ 6.2% vs FY2024
EPS · FY25
$-0.61
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-4.4%
Net margin · FY25
-2.4%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 3.3B
Revenue, FY2025 · full 12-year series below
Revenue
Net income
The company lost 2 cents on every revenue dollar this year.
Per share
USD -0.61
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-4.4%
Return on equity, FY2025
ROE
Operating margin11.8%
Net margin-2.4%
Return on assets-1.0%
Each USD of equity lost 4 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+12.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+9.2%
+12.2%
+13.2%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.13B
Shares outstanding, FY2025
Change, 5 years+4.8%
Change, 10 years—
The share count grew 5% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 8.1B
total assets, end of FY2025
Total assetsUSD 8.1B
EquityUSD 1.7B
CashUSD 239.9M
Gross debtUSD 3.7B
Net debtUSD 3.5B
Current ratio1.87×
Net debt stands at 204% of equity.
History
12 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2016
2015
2014
2013
Revenue $B
3.3
3.1
2.7
2.5
2.2
1.9
1.8
1.8
1.1
1.0
0.4
0.3
Operating income $B
0.4
0.3
0.3
0.3
0.3
0.2
0.2
0.1
0.2
0.1
0.1
0.1
EBITDA $B
0.6
0.5
0.4
0.5
0.4
0.3
0.3
0.1
0.2
0.2
0.1
0.1
Income tax $B
0.0
0.1
−0.0
0.0
0.0
−0.0
0.0
0.0
0.0
−0.1
0.0
0.0
Net income $B
−0.1
−0.2
−0.0
−0.1
−0.1
−0.1
−0.1
−0.2
0.0
0.0
−0.1
−0.0
EPS, diluted $
−0.61
−1.33
−0.09
−0.59
−1.12
−3.19
−2.29
−4.96
0.20
0.04
−2.04
−0.28
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−4.4
−8.9
−0.6
−3.5
−11.8
−56.3
−21.3
−38.8
334.7
·
·
·
Shares out B
0.13
0.13
0.13
0.13
0.09
0.05
0.05
0.05
0.05
0.05
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
36 of 36
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed